developing a suitable model for supplier selection based on supply chain risks: an empirical study from iranian pharmaceutical companies

the supply chain represents the critical link between the development of new product and the market in pharmaceutical industry. over the years, improvements made in supply chain operations have focused largely on ways to reduce cost and gain efficiencies in scale. in addition, powerful regulatory and market forces have provided new incentives for pharmaceutical firms to basically rethink the way they produce and distribute products, and also to re-imagine the role of the supply chain in driving strategic growth, brand differentiation and economic value in the health continuum. the purpose of this paper is to formulate basic factors involved in risk analysis of pharmaceutical industry, and also determine the effective factors involved in suppliers selection and their priorities. this paper is based on the results of literature review, experts’ opinion acquisition, statistical analysis and also using madm models on data gathered from distributed questionnaires. the model consists of the following steps and components: first factors involved in to supply chain risks are determined. based on them a framework is considered. according the result of statistical analysis and madm models the risk factors are formulated. the paper determines the main components and influenceial factors involving in the supply chain risks. results showed that delivery risk can make an important contribution to mitigate the risk of pharmaceutical industry.